Search research articles
Contact Us
Filters
Showing results (1-10 of 425) with videos related to
Page
of 43
Sort By:
The Lancet. Infectious Diseases
|
March 15, 2024
The hidden threat of subclinical tuberculosis
Xiaolin Wei, Wenhong Zhang
Emerging Microbes & Infections
|
June 9, 2026
Henipaviruses at the threshold: preparedness in the era of recurrent spillover
Xinyu Wang, Wenhong Zhang
Journal of Hepatology
|
October 14, 2014
HBeAg-positive chronic hepatitis B patients with prior long-time exposure to nucleos(t)ide analogues: "switch-to" or "add-on" PegIFN alfa, that is the question
Shaolong Chen, Wenhong Zhang
Infectious Diseases & Immunity
|
June 22, 2026
Clinical Trials of Respiratory Virus Infections: How to Address Challenges and Prepare for the Future
Jingwen Ai, Wenhong Zhang
Drug Development Research
|
December 15, 2018
Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging
Yang Li, Feng Sun, Wenhong Zhang
Emerging Microbes & Infections
|
March 27, 2020
Clinical observation and management of COVID-19 patients
Taisheng Li, Hongzhou Lu, Wenhong Zhang
Lancet (London, England)
|
May 9, 2022
Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic
Xinxin Zhang, Wenhong Zhang, Saijuan Chen
Science China. Life Sciences
|
June 28, 2018
The miR-58 microRNA family is regulated by insulin signaling and contributes to lifespan regulation in Caenorhabditis elegans
Yanping Zhang, Wenhong Zhang, Mengqiu Dong
Expert Review of Gastroenterology & Hepatology
|
June 30, 2017
Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinoma
Yiqi Yu, Jingwen Ai, Wenhong Zhang
Frontiers of Medicine
|
March 7, 2022
SARS-CoV-2 variants, immune escape, and countermeasures
Yi Zhang, Haocheng Zhang, Wenhong Zhang
Page
of 43
Search research articles
Search
Showing results (1-10 of 425) with videos related to
Sort By:
Page
of 43
The Lancet. Infectious Diseases
|
March 15, 2024
The hidden threat of subclinical tuberculosis
Xiaolin Wei, Wenhong Zhang
Emerging Microbes & Infections
|
June 9, 2026
Henipaviruses at the threshold: preparedness in the era of recurrent spillover
Xinyu Wang, Wenhong Zhang
Journal of Hepatology
|
October 14, 2014
HBeAg-positive chronic hepatitis B patients with prior long-time exposure to nucleos(t)ide analogues: "switch-to" or "add-on" PegIFN alfa, that is the question
Shaolong Chen, Wenhong Zhang
Infectious Diseases & Immunity
|
June 22, 2026
Clinical Trials of Respiratory Virus Infections: How to Address Challenges and Prepare for the Future
Jingwen Ai, Wenhong Zhang
Drug Development Research
|
December 15, 2018
Bedaquiline and delamanid in the treatment of multidrug-resistant tuberculosis: Promising but challenging
Yang Li, Feng Sun, Wenhong Zhang
Emerging Microbes & Infections
|
March 27, 2020
Clinical observation and management of COVID-19 patients
Taisheng Li, Hongzhou Lu, Wenhong Zhang
Lancet (London, England)
|
May 9, 2022
Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic
Xinxin Zhang, Wenhong Zhang, Saijuan Chen
Science China. Life Sciences
|
June 28, 2018
The miR-58 microRNA family is regulated by insulin signaling and contributes to lifespan regulation in Caenorhabditis elegans
Yanping Zhang, Wenhong Zhang, Mengqiu Dong
Expert Review of Gastroenterology & Hepatology
|
June 30, 2017
Current clinical evidence for nucleos(t)ide analogues in patients with HBV-related hepatocellular carcinoma
Yiqi Yu, Jingwen Ai, Wenhong Zhang
Frontiers of Medicine
|
March 7, 2022
SARS-CoV-2 variants, immune escape, and countermeasures
Yi Zhang, Haocheng Zhang, Wenhong Zhang
Page
of 43